about
Non-cardiovascular effects associated with statinsPolymorphisms in the mitochondrial ribosome recycling factor EF-G2mt/MEF2 compromise cell respiratory function and increase atorvastatin toxicityDevelopment and Content Validity of the Statin Experience Assessment Questionnaire (SEAQ)©.Protocol for analyses of adverse event data from randomized controlled trials of statin therapy.Treatment strategies in patients with statin intolerance: the Cleveland Clinic experience.Statin induced myopathy presenting as mechanical musculoskeletal pain observed in two chiropractic patients.Discontinuation of statins in routine care settings: a cohort study.Reasons for discontinuation of lipid-lowering medications in patients with chronic kidney disease.Statin use and musculoskeletal pain among adults with and without arthritis.Communicating statin evidence to support shared decision-making.National Assessment of Statin Therapy in Patients Hospitalized with Acute Myocardial Infarction: Insight from China PEACE-Retrospective AMI Study, 2001, 2006, 2011Drivers of the Sex Disparity in Statin Therapy in Patients with Coronary Artery Disease: A Cohort StudyTreatment Options for Statin-Associated Muscle Symptoms.SLCO1B1 genetic variants, long-term low-density lipoprotein cholesterol levels and clinical events in patients following cardiac catheterization.The role of acid-base imbalance in statin-induced myotoxicityStatin-induced myopathy in a usual care setting-a prospective observational study of gender differencesStatin-induced muscle damage and atrogin-1 induction is the result of a geranylgeranylation defect.Management of hyperlipidemia in older adults.Animal models of catheter-induced intimal hyperplasia in type 1 and type 2 diabetes and the effects of pharmacologic intervention.The controversy of a wider statin utilization: why?Statin-associated autoimmune myopathy and anti-HMGCR autoantibodies.Statin myopathy: the fly in the ointment for the prevention of cardiovascular disease in the 21st century?Muscle- and skeletal-related side-effects of statins: tip of the iceberg?Current drug treatment of hyperlipidemia in older adults.Associations of statin use with motor performance and myalgia may be modified by 25-hydroxyvitamin D: findings from a British birth cohort.Approach to Statin Use in 2016: an Update.Sociodemographic factors are associated with utilisation of statins after ischaemic stroke/TIA.Tendon, tendon healing, hyperlipidemia and statinsNitric oxide prevents atorvastatin-induced skeletal muscle dysfunction and alterations in mice.Statin-associated Autoimmune Myopathies: A Pathophysiologic Spectrum.Statin use and pain in older people with cancer: a cross-sectional study.Fibromyalgia has a high prevalence and impact in cardiac failure patients.Statin related adverse effects and patient education: a study from resource limited settings.Association of Statin Use With Risk of Back Disorder Diagnoses.Overenthusiastic stroke risk factor modification in the over-80s: are we being disingenuous to ourselves, and to our oldest patients?Cholesterol screening and management in children and young adults should start early--NO!Low vitamin D does not predict statin associated muscle symptoms but is associated with transient increases in muscle damage and pain.Characterization of Statin-Associated Myopathy Case Reports in Thailand Using the Health Product Vigilance Center Database.
P2860
Q27026332-CB95F59D-0831-44E5-94D9-410321A90FCCQ28480419-BEA580B5-2EC2-4927-A205-9D343CB19486Q30848030-E8ED9C60-5A23-4F94-929A-A9E35A064938Q31105715-F2C4DA04-1AA4-492E-B80D-BBDEE3ADB493Q33684643-23A62986-2E0E-4AB8-8E51-36B3EEFF0387Q33692765-F23416ED-E7D2-4BE7-B6A4-8E71B97FE06DQ34644409-4DDC2FE0-DFB7-4939-8FDB-43F601895856Q34985796-E0D3DF7D-D71E-4041-AA96-DCCB3D373A8AQ35697228-704F7D41-1776-46CD-A0D0-F431222AE4A9Q35980419-3294504E-0581-46E5-A26D-F63C0D211039Q35983833-5C2EAD09-2293-4EB5-8341-3D4A51F550E3Q36009362-609B077E-B036-4457-84C9-F9CAB0B76747Q36294394-F9E61D38-FC31-4E33-849A-72AAEAB67849Q36480609-B1F4C22D-5A80-4055-ACA5-F5301482B55AQ37140174-660969A9-1DBB-43E2-AB1F-71E99F673748Q37253606-E35B0034-A64C-420E-9F19-20BFC12CE4F6Q37326940-15E2D31D-8291-473A-A43C-A4C8197E085EQ37362818-FA7EB393-BC19-44EA-A207-CF3AB5643AE3Q37367896-905F4C7A-2D79-4E20-8901-6947569C55E4Q38089090-F79D3ACD-EC3A-4D37-87B1-5AA19DD2FB01Q38092053-1FD9091A-3757-46A8-8F74-307B0329B331Q38228757-2D443182-403F-4DB2-A118-62B1540021D9Q38250622-ED8BDB9A-7287-4D76-91E8-CCCC81F2E273Q38338437-B9692D2F-CE6C-40A5-B4F6-BFB1E51FAFD3Q38651358-8C99A625-2831-4153-BAE6-F4414B39EDDAQ38773373-38446800-446C-43DC-AE8C-358706D68FB3Q38859013-A9C12603-C7F6-442C-A2C7-CEEEF341A656Q41145100-99003111-37C0-4711-8881-40BB06A2446FQ44291723-142A8672-F0FE-4D15-BEE0-D939549E030EQ46066815-2C722D79-B623-457F-9122-9E1704801C58Q46975648-F7B20E7C-D837-4B24-8510-7FE755C710DFQ47168498-215D0B38-B34B-49F2-947D-37B94652A128Q47407410-624188D2-DD46-4DE9-B083-597DAC1A557DQ47900963-4E53F025-A093-4679-B73D-9DBBF0B768DCQ48330325-A0BB4BEF-2DFB-4A63-BA9D-0CC114E49B38Q50895846-5245E60C-241B-4BF2-AA77-93B5813303AAQ51001582-1F3A7927-391D-4C55-A93F-C7DC622B9945Q51248618-833BD7C8-6C7B-42B0-989B-0E9254D50330
P2860
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Prevalence of musculoskeletal pain and statin use.
@en
type
label
Prevalence of musculoskeletal pain and statin use.
@en
prefLabel
Prevalence of musculoskeletal pain and statin use.
@en
P2093
P2860
P1476
Prevalence of musculoskeletal pain and statin use.
@en
P2093
Catherine Buettner
Kenneth J Mukamal
Roger B Davis
Suzanne G Leveille
P2860
P2888
P304
P356
10.1007/S11606-008-0636-7
P577
2008-05-01T00:00:00Z